Author Biographies

N/A
N/A
N/A
Dong-Kwon Lim is an associate professor at the KU-KIST Graduate School of Science and Technology at Korea University (Seoul, South Korea) (2015~current). After he finished his BS and MS degrees in chemistry from Kyungpook National University (1996), he worked for more than 10 years in the pharmaceutical research institutes of the company in Korea. After he received his Ph.D. degree in Chemistry from Seoul National University in 2011, he started his postdoctoral research at MIT (David H. Koch Institutes, Advisor: Prof. Robert Langer Lab) and Harvard Medical School (Children’s Hospital Boston) (2011~2013). He has made pioneering contributions to the field of DNA-based nanostructure synthesis for single-molecule surface-enhanced Raman scattering (SERS) and the development of new bio-detection and therapeutic strategies based on organic/inorganic hybrid nanomaterials. Another field he is focusing on is the use of plasmonic nanomaterials as photocatalysts for various reactions, such as CO2 conversion and C-C coupling reactions.
Kwangmeyung Kim is an academic researcher from the Korea Institute of Science and Technology and a Distinguished Professor at the College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University. He obtained his B.Sc. at Sungkyunkwan University in Chemical Engineering in 1997, his M.Sc. at the Gwangju Institute of Science and Technology (GIST) in 1999, and his Ph.D. at the Gwangju Institute of Science and Technology (GIST) in 2003. He was awarded an “Excellent Research Scientist” by the Korea Institute of Science and Technology (KIST) in 2010, a “Prime Minister’s Commendation” by the Government of the Republic of Korea in 2013, and a “Medal of Honor in Science and Technology” by the Government of the Republic of Korea in 2019. His research interests focus on how theranostic biomaterials can be designed with tumor-specific fluorescence imaging probes, especially tumor-specifically activatable imaging probes, which in turn can be switched to therapeutic design with identical principles. He has an h-index of 87 and has co-authored more than 374 publications, receiving 26,416 citations (Scopus, November 2, 2023).
clear